Description
Created On: 2020-07-15
Record Count: 3
Primary Industries
- Drugs
- Cancer
- Disease
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 273286
Licensor grants an exclusive right and license,including with respect to Licensor, with the right to grant sublicenses, under Licensor Intellectual Property, to Commercialize the Product in the Field in the Licensee Territory.
Licensor grants a non-exclusive right and license, with the right to grant sublicenses, under Licensor Intellectual Property, to Manufacture Product for use in the Field.
Product shall mean a product containing or consisting of the Compound for use solely by intra-vitreous delivery via injection.
Licensee conducted a non-clinical study of DX-88 for the treatment of macular edema associated with retinal vein occlusion.
IPSCIO Record ID: 273855
Licensor grants an exclusive right and license, including with respect to Licensor, with the right to grant sublicenses, under Licensor Intellectual Property and Licensor Product Intellectual Property, to Commercialize the Product in the Field in the Licensee Territory and an exclusive right and license, including with respect to Licensor, with the right to grant sublicenses, under Licensor Product Intellectual Property, to Commercialize the Product outside the Field in the Licensee Territory.
Licensor grants a non-exclusive right and license, with the right to grant sublicenses, under Licensor Intellectual Property and Licensor Product Intellectual Property, to Manufacture Finished Product.
Licensor grants a non-exclusive right and license, with the right to grant sublicenses, under Licensor Product Intellectual Property to Develop, Manufacture and Commercialize products containing the Compound outside the Field in the Licensee Territory and/or the Licensor Territory.
Product shall mean a product containing or consisting of the Compound for use solely by intra-vitreous delivery via injection.
The Licensors patents are titled Compositions and Methods for Treating Ophthalmic Disorders.
IPSCIO Record ID: 203245
Licensor grants an exclusive license under Licensor Intellectual Property, with the right to grant sublicenses, to Manufacture and have Manufactured Drug Substance and Drug Product for use by or on behalf of Licensee, its Affiliates, Sublicensees and Third Party contractors for the Development and Commercialization of Product in Field in Licensees Territory.
Products incorporating DX-88 is for the treatment of angioedemas.
Angioedema is an area of swelling of the lower layer of skin and tissue just under the skin or mucous membranes. The swelling may occur in the face, tongue, larynx, abdomen, or arms and legs. Often it is associated with hives, which are swelling within the upper skin.
